ERAS
ERASCA (ERAS)
NASDAQ
$16.10+$0.22 (+1.37%)
Price as of Sep 11, 2026 7:55 PM EDT
  • $5.6B
    Market Cap
  • 917.95%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

N/A
Valuation
ERAS
vs History
vs S&P 500
Profitability
-1
Growth
-0
Low Earnings Volatility
0

Momentum Score

Score: 61
Valuation
ERAS
vs History
vs S&P 500
3-Month Momentum
38.55%
12-Month Momentum
1,054.04%
3-Month Risk Adjusted Momentum
129.48%
12-Month Risk Adjusted Momentum
1,036.99%

True Yield

N/A
Valuation
ERAS
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
N/A
Net Debt Paydown Yield
N/A

Financial Health Score

N/A
Valuation
ERAS
vs History
vs S&P 500
Ohlson's O-Score
-1